Abstract: This application relates to the field of liquid cooling technologies, and provides a gas collection apparatus, configured to collect bubbles generated due to loss of a working medium in a liquid cooling apparatus. The gas collection apparatus includes a cooling plate. The cooling plate includes at least one gas collection structure disposed inside the cooling plate, a first flow channel disposed inside the cooling plate, a second flow channel disposed inside the gas collection structure, and at least one connecting channel configured to connect the first flow channel and the second flow channel. The at least one connecting channel is configured to transfer, to the second flow channel, bubbles carried when the working medium flows in the first flow channel. The at least one gas collection structure is configured to collect the bubbles from the second flow channel.

Abstract: Systems and methods for defending against volumetric attacks, implemented in a cloud-based system. Embodiments include steps of, monitoring flows and a rate of requests to a Data Center (DC); receiving a request from an address to the DC, the request being for a service in a cloud-based system; determining if the address has been successfully authenticated within a past predetermined time period; responsive to the address not having been successfully authenticated within the past time period, and one of (i) the rate of requests being above a threshold or (ii) the number of flows being above a threshold, placing the address in a penalty box for a predetermined amount of time; and blocking requests from the address in the penalty box for the predetermined amount of time.

Abstract: A method, an apparatus, a terminal and a storage medium for display control is provided by the disclosure. The disclosure provides a method of display control which includes: displaying, in a display area of a target application, at least part of pages opened in the target application, if a number of pages opened in the target application exceeds n, displaying n opened pages in the display area of the target application and hiding other pages, and displaying a page identifier of a hidden page, n being not less than 1; and in response to a triggering operation on the page identifier, displaying a page corresponding to the triggered page identifier in the display area of the target application.

Abstract: Disclosed in the present invention are a series of fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compounds and the use thereof. Specifically disclosed are a compound represented by formula (H) and a pharmaceutically acceptable salt thereof.

Abstract: A polypeptide compound having a structure shown in formula I, or a stereoisomer, mixture or pharmaceutically acceptable salt thereof Experimental results show that the polypeptide compound can effectively exhibit high agonistic activity to GHSR-1a.

Abstract: This application provides example communication methods and devices to improve wireless local area network (WLAN) communication efficiency. In an example method, an access point (AP) sends first indication information. The first indication information indicates a first resource unit (RU) of a station (STA). The AP sends second indication information. The second indication information indicates whether the STA is allowed to send a physical layer protocol data unit (PPDU) based on a part of the first RU, and when the second indication information indicates that the STA is allowed to send the PPDU based on the part of the first RU. The PPDU includes a low density parity check (LDPC) extra symbol segment. The AP receives a first PPDU. A second RU occupied by the first PPDU is the part of the first RU. The first PPDU includes the LDPC extra symbol segment.

Abstract: The present invention discloses a heteroatom- and cycloalkyl-containing organic compound and an organic electroluminescent device containing the compound. The general structural formula of the organic compound is as represented by Formula I. The organic compound has a boron-nitrogen structure with multiple resonance effect, wherein a cycloalkyl-containing fluorenyl structure is introduced on the basis of the boron-nitrogen structure. The molecular size is greatly expanded by means of the cycloalkyl group, thereby effectively avoiding a concentration quenching effect, while the molecular orientation is enhanced due to the planarity of the fluorenyl group.

Abstract: This application relates to the wireless communications field, for example, is applicable to a wireless local area network supporting the 802.11be standard, and in particular, to a PPDU uplink bandwidth indication method and a related apparatus. The method includes: An AP generates and sends a trigger frame. The trigger frame carries first indication information, where the first indication information directly indicates or jointly indicates an EHT TB PPDU bandwidth or an uplink PPDU total transmission bandwidth. The trigger frame carries second indication information, where the second indication information indicates distribution of an HE TB PPDU and/or an EHT TB PPDU in the uplink PPDU total transmission bandwidth, or directly indicate whether an EHT station transmits an HE TB PPDU or an EHT TB PPDU.

Abstract: An array substrate includes: a first substrate (10), including a plurality of sub-pixel regions (101) arranged in an array along a row direction (X) and a column direction (Y); a pixel circuit layer, including a plurality of sub-pixel circuits; a planarization layer (17), provided with a first via hole (170) located in the sub-pixel regions (101), and includes at least one pattern portion (171), the pattern portion (171) includes a plurality of pattern units (171a) arranged in an array along the row direction (X) and the column direction (Y); and a reflective electrode layer, wherein the reflective electrode layer includes a plurality of reflective electrodes (18) that are mutually disconnected, each of the reflective electrodes (18) is located in one of the sub-pixel regions (101) and is electrically connected to the sub-pixel circuit through the first via hole (170).

Abstract: A barrier structure for bearing a high-energy impact and construction method thereof are provided. The barrier structure includes a supporting pile array arranged between two opposite mountain slope surfaces. The supporting pile array is arranged in a straight line and includes two or more supporting piles. The two or more supporting piles are fixed at a lower part of a mountain. A barrier net is connected to the two or more supporting piles. The barrier net passes through the supporting pile array and extends to the two opposite mountain slope surfaces. The barrier net is fixed on the two opposite mountain slope surfaces. Pull plates are disposed on the two opposite mountain slope surfaces, and one side of each of the pull plates is fixed to a corresponding slope surface of the two opposite mountain slope surfaces through reverse prestressed anchor cables.

Abstract: The present disclosure provides an N protein epitope mutation marker for preparing an epitope deletion-marked vaccine strain of type II porcine reproductive and respiratory syndrome virus (PRRSV) and use thereof, belonging to the technical field of biological products. In the mutation marker, one or more amino acids are mutated based on an epitope sequence at positions 92 to 103 of a C-terminal of an N protein of the type II PRRSV; and the epitope mutation marker has an amino acid sequence shown in SEQ ID NO: 1, where X1 is selected from the group consisting of T, P, and A; and X2 is selected from the group consisting of V and A.

Abstract: The present invention relates to an S-configuration-containing amino benzamide pyridazinone compound, a preparation method therefor, and a pharmaceutical composition and application thereof. Specifically, the present invention relates to a compound represented by the following general formula I or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition and application thereof. The S-configuration compound of the present application has very strong binding activity on class I histone deacetylase (HDAC1), and shows inhibitory activity on in-vitro proliferation of various tumor cells.

Abstract: A method and system for predicting water flooding recovery of fault block reservoirs considering a whole process optimization includes: determining influencing factors in water flooding recovery of fault block reservoirs; screening master parameters of the water flooding recovery of the fault block reservoirs; determining a single-factor correlation between the water flooding recovery of the fault block reservoirs and the master parameters; designing multi-factor orthogonal experimental schemes; performing a whole-process water flooding optimization for each of the experimental schemes including separate-layer injection and production, well-type conversion, and injection and production adjustment, to obtain the maximum water flooding recovery; and determining a prediction model of the water flooding recovery of the fault block reservoirs using least square method based on results of the whole process optimization of orthogonal experiments, further obtaining a prediction model of the water flooding recovery of

Abstract: The present invention discloses a right-angle turning method for small-diameter TBM exploration adit excavation and belongs to the field of geological exploration of water conservancy and hydropower projects.

Abstract: This application provides a pilot signal transmission method and a related apparatus. The method includes: A first device determines a first frequency band to which a discrete RU allocated to the first device belongs; and the first device sends a first pilot signal of the first device to a second device on all pilot subcarriers included in the first frequency band. According to embodiments of this application, problems such as narrowband interference and frequency selective fading are avoided, and pilot signal transmission reliability is improved.

Abstract: Provided herein are compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions: wherein R1, R2, R3a, R3b, R4, R5, and A are defined in the present disclosure. The compounds are potent inhibitors of the main protease (Mpro) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), and they are useful in treating or preventing COVID-19 in a subject.

Abstract: A method for producing adipic acid and cyclohexanone oxime from cyclohexane is provided. Cyclohexane and NOx undergo oxidation-nitration reaction to produce a mixture of adipic acid, nitrocyclohexane, nitrogen oxides and by-product A, from which adipic acid and nitrocyclohexane are separated. The nitrocyclohexane is catalytically hydrogenated with hydrogen to produce cyclohexanone oxime and a small amount of cyclohexylamine, where cyclohexanone oxime is collected, and the cyclohexylamine is partially oxidized with molecular oxygen to obtain cyclohexanone oxime and by-product B. Without separation, or after removing part or all of water from the reaction mixture, under the action of a catalyst, the reaction mixture undergoes hydrogenation and amination simultaneously or sequentially, or the hydrogenation alone, and separation to give cyclohexanone oxime.

Abstract: Disclosed is the use of a water-soluble realgar solid dispersion in the preparation of an erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells. The water-soluble realgar solid dispersion is prepared from raw materials comprising 1 part by weight of realgar, 1-20 parts by weight of a polymer, and 0-5 parts by weight of a surfactant. The water-soluble realgar solid dispersion can induce bone marrow hematopoietic stem and/or progenitor cells to be differentiated into red blood cells, promote the accumulation of red blood cells in bone marrow cells, effectively alleviate the decrease in the number of red blood cells caused by the suppression of the erythroid differentiation of bone marrow hematopoietic stem and/or progenitor cells, improve anemia caused by hematopoietic failure, and protect bone marrow cells from the killing effect.

Abstract: The present invention relates to Compounds of Formula I and Ia and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, X, A and B are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula I or Ia, and methods of using the compounds of Formula I or Ia for treating or preventing HIV infection in a subject.

Abstract: A display device is provided, including: a back plate; a plastic frame connected to the back plate; a backlight module; a privacy film on a light emitting side of the backlight module; and a dimming sheet on a side of privacy film away from the back plate, wherein the dimming sheet is configured to be capable of adjusting a viewing angle of the display device. The plastic frame includes a first surface and a side end face, the first surface is a surface of the plastic frame close to the dimming sheet, the side end face is a side face of the plastic frame close to the dimming sheet, the plastic frame further includes a chamfered portion at a transition position between the side end face and the first surface, and the chamfered portion has a rough surface that is configured for diffracting the light incident on the chamfered portion.